期刊文献+

残留型精神分裂症患者肠道菌群特点初探

A preliminary study of intestinal flora in patients with residual schizophrenia
下载PDF
导出
摘要 目的:初探残留型精神分裂症患者的肠道菌群特点。方法:选取20名残留型精神分裂症患者作为观察组,20名健康人作为对照组,对两组人群的粪便样本进行检测。通过"各个样品的总基因组DNA提取"、"16S r DNA的荧光PCR扩增"、"PCR扩增产物纯化"、"PCR纯化产物酶切"、"酶切产物脱盐"、"电泳进样体系和电泳参数"、"T-RFLP图谱生成"和"T-RFLP数据处理"等7个步骤而得出相应的结果。结果:两组的肠道微生物群落之间存在明显的差异。结论:残留型精神分裂症的肠道菌群与健康人存在差异。 Objective: To preliminarily investigate characteristics of intestinal flora of patients with residual schizophrenia.Methods: A total of 20 patients with residual schizophrenia were selected as the observation group,and 20 healthy subjects were used as the control group.Their fecal samples were collected for the study.The corresponding results were got through 7 steps,including total genomic DNA extractionofvarious samples,16 S rDNA fluorescent PCR amplification,purification of the PCR amplified products,PCR purified product enzyme digestion,desalting of the enzyme digested products,electrophoresis sample system and electrophoresis parameters,T-RFLP map generation and T-RFLP data processing.Results: There was a marked difference between the intestinal micro-biota between the observation group and the control group.Conclusions: The intestinal flora of the residual schizophrenics is different from that of the healthy people.
出处 《中国民康医学》 2017年第14期71-72,共2页 Medical Journal of Chinese People’s Health
关键词 残留型精神分裂症 肠道菌群 Residual schizophrenia Intestinal flora
  • 相关文献

参考文献5

二级参考文献38

  • 1周俊,段丽萍.多巴胺在胃肠道黏膜保护中的作用及机制[J].中国新药杂志,2004,13(11):981-983. 被引量:3
  • 2李合国,劳绍贤,张峰.益气养阴活血汤对慢性萎缩性胃炎胃黏膜三叶因子-1的影响[J].上海中医药杂志,2005,39(10):22-23. 被引量:16
  • 3功能性胃肠病罗马Ⅲ诊断标准[J].胃肠病学,2006,11(12):761-765. 被引量:746
  • 4OZUCELIK D N.KARACA M A.SIVRI B. Effectivenessof pre-emptive metoclopramide infusion in alleviating pain,discomfort and nausea associated with nasogastric tube in-sertion :a randomized, double-blind, placebo-controlled trial[J]. Int J Clin Pract,2005,59:1422 -1427.
  • 5LEVEIN N G,THORN S E'WATTWIL M. Effects ofclonidine and dopamine on gastric tone[J]. Eur J An-aesthesiol, 2002,19 :99 -104.
  • 6梁鹏.促胃肠动力药物探析[J].医药前沿,2011,20(1):18-19.
  • 7BASSIL A K,DASS N B,MURRAY C D,et al. Proki-neticin-2 , motilin,ghrelin and metoclopramide: proki-netic utility in mouse stomach and colon [ J]. Eur JPharmacol, 2005,524(1 - 3) : 328 - 332.
  • 8AMARAPURKAR D N'RANE P. Randomised, doub-le-blind ,comparative study to evaluate the efficacy andsafety of ganaton(itopridehydrochloride)and mosapridecitrate in the management of functional dyspepsiaQJ. JIndian Med Assoc,2004,102:735 - 737,760.
  • 9FAGENHOLZ P J,FERNANDEZ-DEL C C, HARRISN S,et al. Direct medical costs of acute pancreatitishospitalizations in the United States [J]. Pancreas,2007,35:302-307.
  • 10LIN Z. MADRAS B K. Human genetics and pharma-cology of neurotransmitter transporters[J]. Handb ExpPharmacol,2006 ,175:327 -376.

共引文献196

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部